INT79253

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.61
First Reported 1998
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.20
Pain Relevance 0.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (ST3GAL4) Golgi apparatus (ST3GAL4)
ST3GAL4 (Homo sapiens)
Pain Link Frequency Relevance Heat
agonist 2 96.84 Very High Very High Very High
Pain 2 96.20 Very High Very High Very High
Nicotine 2 94.96 High High
cINOD 9 5.00 Very Low Very Low Very Low
aspirin 7 5.00 Very Low Very Low Very Low
Action potential 5 5.00 Very Low Very Low Very Low
medulla 4 5.00 Very Low Very Low Very Low
Migraine 3 5.00 Very Low Very Low Very Low
depression 2 5.00 Very Low Very Low Very Low
cerebral cortex 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Breast Cancer 45 98.44 Very High Very High Very High
Cancer 7 97.32 Very High Very High Very High
Disease 5 96.68 Very High Very High Very High
Pain 1 96.20 Very High Very High Very High
Recurrence 1 85.36 High High
Arrhythmias 2 Under Development 7 81.88 Quite High
Heart Rate Under Development 7 80.72 Quite High
Obesity 7 5.00 Very Low Very Low Very Low
Cardiovascular Disease 7 5.00 Very Low Very Low Very Low
Cognitive Disorder 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Compound 2 (SIB-1663), which selectively activated human recombinant alpha 2 beta 4 and alpha 4 beta 4 nAChRs, was shown to be active in animal models of Parkinson's disease and pain.
Positive_regulation (activated) of recombinant alpha 2 beta 4 associated with pain and disease
1) Confidence 0.61 Published 1998 Journal Bioorg. Med. Chem. Lett. Section Abstract Doc Link 9873508 Disease Relevance 0.19 Pain Relevance 0.23
However, the region of stimulus repetition-rates above and below which the A-waves show clear changes in waveform is the STZ, which in vision can be described without much specificity as "where the flicker changes to fusion".
Positive_regulation (described) of STZ
2) Confidence 0.35 Published 2006 Journal BMC Neurosci Section Body Doc Link PMC1483834 Disease Relevance 0 Pain Relevance 0
Women in the cohort who were taking CGs (mostly digoxin) at the time of their breast cancer diagnosis had tumors with less aggressive phenotypes than breast tumors of women not taking CGs [2].
Positive_regulation (taking) of CGs associated with cancer and breast cancer
3) Confidence 0.07 Published 2008 Journal Breast Cancer Res Section Body Doc Link PMC2656898 Disease Relevance 1.00 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox